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Background
It has been reported that a part of asthma patients does
not respond well to inhaled corticosteroids (ICS) and the
benefit by long term treatment by high-dose ICS is limited
in such patients. But the clinical or genetic factors for pre-
dicting ICS response have not been fully established espe-
cially in adults. The aim of this study is to establish the
factor for predicting the response to ICS treatment.
Method
Patients treated only by ICS for more than 6 months
were enrolled and classified into responder group
(R group, n=30) if FEV1 improvement ≥ 5% and non-
responder group (NR group, n=40, FEV1 improvement
<5%). The relationship between ICS response and pre-
treatment clinical indices and 21 single nucleotide poly-
morphism (SNP) were retrospectively analyzed.
Results
In R group, peripheral blood eosinophil % (R: NR = 7.5:
4.3%) and serum total IgE level (550.4: 497.1 U/ml) was
significantly higher as compared to NR group. R group
also showed significantly lower %VC (97.5: 114.8%), %
FEV1.0 (77.9: 101.3%), FEV1.0% (67.5: 76.4%) and higher
bronchial hyperresponsiveness. Bronchial reversibility test
was available in 30 patients (R: n=11, NR: n=19) and rever-
sibility was significantly higher in R group (15.9: 5.4%). By
logistic multivariate analysis for those 30 patients, bron-
chial reversibility was significantly related to ICS response.
SNP in IFN-g R1 L467P was also related to ICS response.
Post/Pre FEV1 ratio was significantly higher in homo/
hetero group as compared to wild group (140.2 v.s 108.8%).
Conclusion
Pre-treatment bronchial reversibility was identified as a
prediction factor for ICS response. It has been reported
that SNP in IFN-gR is associated with allergic diseases
and serum IgE level and the SNP might be potentially
related to ICS response.
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